Aura Biosciences annual current ratio
2020
2021
2022
2023
2024
2025
Aura Biosciences Current Ratio Growth & History (AURA)
Aura Biosciences's current ratio was 8.15 for fiscal 2025.
View full Aura Biosciences company overviewAura Biosciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 8.15 | −2.63 | −24.37% |
| 2024 | 2024-12-31 | 10.77 | −7.99 | −42.58% |
| 2023 | 2023-12-31 | 18.76 | −0.05 | −0.28% |
| 2022 | 2022-12-31 | 18.81 | −2.09 | −9.99% |
| 2021 | 2021-12-31 | 20.90 | 13.96 | +201.32% |
| 2020 | 2020-12-31 | 6.94 | — | — |
Aura Biosciences quarterly current ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 16.82 | 4.44 | +35.81% |
| Q1 2026 | 2026-03-31 | 7.09 | −3.97 | −35.86% |
| Q4 2025 | 2025-12-31 | 8.15 | −2.63 | −24.37% |
| Q3 2025 | 2025-09-30 | 9.04 | −3.43 | −27.52% |
| Q2 2025 | 2025-06-30 | 12.39 | −6.16 | −33.21% |
| Q1 2025 | 2025-03-31 | 11.06 | −10.91 | −49.65% |
| Q4 2024 | 2024-12-31 | 10.77 | −7.99 | −42.58% |
| Q3 2024 | 2024-09-30 | 12.47 | −1.66 | −11.72% |
| Q2 2024 | 2024-06-30 | 18.54 | −0.14 | −0.76% |
| Q1 2024 | 2024-03-31 | 21.97 | −0.13 | −0.59% |
| Q4 2023 | 2023-12-31 | 18.76 | −0.05 | −0.28% |
| Q3 2023 | 2023-09-30 | 14.13 | 2.49 | +21.43% |
| Q2 2023 | 2023-06-30 | 18.69 | −3.28 | −14.93% |
| Q1 2023 | 2023-03-31 | 22.09 | −5.81 | −20.81% |
| Q4 2022 | 2022-12-31 | 18.81 | −2.09 | −9.99% |
| Q3 2022 | 2022-09-30 | 11.63 | −2.68 | −18.73% |
| Q2 2022 | 2022-06-30 | 21.97 | — | — |
| Q1 2022 | 2022-03-31 | 27.90 | — | — |
| Q4 2021 | 2021-12-31 | 20.90 | 13.96 | +201.32% |
| Q3 2021 | 2021-09-30 | 14.31 | — | — |
| Q4 2020 | 2020-12-31 | 6.94 | — | — |
Aura Biosciences current ratio trends
Over the last five fiscal years, Aura Biosciences's current ratio increased from 6.94 to 8.15, a change of 1.21. The latest reported quarter, Q2 2026, shows 16.82.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aura Biosciences source filings ↗